Calvin Yu

No open positions remaining

50 year

Health Technology

Consumer Services

Profile

Calvin Yu worked as Senior Director-Finance & SEC Reporting at Adverum Biotechnologies, Inc. from 2014 to 2016.
Prior to that, he worked as Controller at Five Prime Therapeutics, Inc. from 2010 to 2014.
He also worked as Controller at Stemcentrx, Inc. from 2016 to 2017.
Currently, he is the Chief Financial & Accounting Officer at Alector, Inc. Mr. Yu completed his undergraduate degree from San Francisco State University.

Former positions of Calvin Yu

Companies	Position	End
Stemcentrx, Inc. Stemcentrx, Inc. BiotechnologyHealth Technology Develops life-changing therapies for cancer patients	Comptroller/Controller/Auditor	2017-05-31
ADVERUM BIOTECHNOLOGIES, INC.	Director of Finance/CFO	2016-01-31
FIVE PRIME THERAPEUTICS, INC.	Comptroller/Controller/Auditor	2014-08-31
ALECTOR, INC.	Director of Finance/CFO	2021-09-07

See the detail of Calvin Yu's experience

Training of Calvin Yu

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Calvin Yu's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Five Prime Therapeutics, Inc. Five Prime Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops protein therapeutics for cancer and inflammatory diseases	Health Technology
Stemcentrx, Inc. Stemcentrx, Inc. BiotechnologyHealth Technology Develops life-changing therapies for cancer patients	Health Technology
San Francisco State University San Francisco State University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Adverum Biotechnologies, Inc. Adverum Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells novel gene therapies	Health Technology
Alector, Inc. Alector, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for Alzheimer’s disease and other neurodegenerative disorders	Health Technology

See company connections